| Serial Number | 87352575 |
| Word Mark | TEVA |
| Filing Date | Tuesday, February 28, 2017 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 15, 2020 |
| Registration Number | 6222131 |
| Registration Date | Tuesday, December 15, 2020 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 26, 2017 |
| Description of Mark | The mark consists of a line design that begins at the bottom center and rises up to the center right side. In the bottom right hand corner is the word TEVA with the letter v formed by 2 leaf shapes. |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system |
| Translation of Words in Mark | The English translation of "TEVA" in the mark is "NATURE". |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 7, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, September 21, 2020 |
| First Use In Commerce Date | Monday, September 21, 2020 |
| Party Name | Teva Pharmaceutical Industries Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Jerusalem 91010 IL |
| Party Name | Teva Pharmaceutical Industries Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Jerusalem 91010 IL |
| Party Name | Teva Pharmaceutical Industries Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Jerusalem 91010 IL |
| Event Date | Event Description |
| Friday, March 3, 2017 | NEW APPLICATION ENTERED |
| Tuesday, March 7, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 8, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 23, 2017 | ASSIGNED TO EXAMINER |
| Friday, May 26, 2017 | PRIORITY ACTION WRITTEN |
| Friday, May 26, 2017 | PRIORITY ACTION E-MAILED |
| Friday, May 26, 2017 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Tuesday, November 14, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 14, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 14, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 17, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, November 17, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 17, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 17, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 17, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 6, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 26, 2017 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 26, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 20, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, August 13, 2018 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 13, 2018 | SOU EXTENSION 1 FILED |
| Monday, August 13, 2018 | SOU EXTENSION 1 GRANTED |
| Wednesday, August 15, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 13, 2019 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 13, 2019 | SOU EXTENSION 2 FILED |
| Wednesday, February 13, 2019 | SOU EXTENSION 2 GRANTED |
| Friday, February 15, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 13, 2019 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 13, 2019 | SOU EXTENSION 3 FILED |
| Tuesday, August 13, 2019 | SOU EXTENSION 3 GRANTED |
| Thursday, August 15, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 19, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 19, 2020 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 19, 2020 | SOU EXTENSION 4 FILED |
| Wednesday, February 19, 2020 | SOU EXTENSION 4 GRANTED |
| Saturday, February 29, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 13, 2020 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 18, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 13, 2020 | SOU EXTENSION 5 FILED |
| Friday, August 21, 2020 | SOU EXTENSION 5 GRANTED |
| Saturday, August 22, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, October 20, 2020 | TEAS STATEMENT OF USE RECEIVED |
| Tuesday, October 20, 2020 | USE AMENDMENT FILED |
| Friday, October 30, 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, November 5, 2020 | SU-EXAMINER'S AMENDMENT WRITTEN |
| Thursday, November 5, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 5, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 5, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Monday, November 9, 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, November 10, 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, December 15, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Monday, December 15, 2025 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |